Genesis Innovation Group

CEO of Genesis Innovation Group and its subsidiary Capitan Orthopedics, with more than 31 years in the medical device industry focused on orthopedic innovation and commercialization. Previously served as Chief Commercial Officer at Skeletal Dynamics and VP at Stanmore Implants (acquired by Stryker in 2016), with earlier roles at Zimmer and Synthes Trauma.

Co-founder of Genesis and a 25-year orthopedic industry veteran with R&D roles at Zimmer, Depuy, DVO, and Tornier. A prolific inventor with more than 50 issued or pending patents.

Senior Technical Director with over 20 years of orthopedic R&D experience across materials research, product testing, and product development, having led commercialization of over a dozen implant systems with 8 issued patents.

Orthopedic R&D leader with over 20 years spanning materials research, product testing, and development. Led commercialization of more than a dozen implant systems and holds 8 issued patents and over 20 scientific publications.

MD, MBA and Managing Director of the cultivate(MD) Venture Capital Fund, and board member of Genesis and Capitan Orthopedics. A shoulder reconstruction specialist with over 20 years of experience, inventor of the first FDA-approved stemless shoulder replacement, holding more than 20 patents.

Co-founder of Genesis with nearly two decades bringing medical device technologies, including proprietary orthopedic materials, to market. Holds more than 30 issued or pending patents.

VP of Quality with over 14 years in medical devices specializing in quality engineering and systems for orthopedics and electromechanical devices. Previously held quality leadership roles at Paragon 28, Zynex Medical, and Zimmer Biomet Spine.

Medical device quality engineering specialist with over 14 years in orthopedics and electromechanical devices. Previously held quality leadership roles at Paragon 28, Zynex Medical, and Zimmer Biomet Spine.